Professor • Director, Stanford Pain Relief Innovations Lab • Chief Science Advisor: AppliedVR • Writing about pain, stress, health & solutions
Stanford University
Joined June 2014
- Tweets7.5K
- Following1.3K
- Followers10.2K
- Likes7.5K
"Personalize opioid tapering for best results". Thank you ACP for including results for our PCORI-funded national tapering study, and our Stanford Patient-Centered Opioid Tapering Toolkit -- a free online resource for clinicians, patients and families tinyurl.com/478whpv5
Shocked to see NIH eliminating K-award funded clinical trials.
instead mentees are expected to pair with mentored funded trials or seek other trial funding sources science.org/content/article/…
Beth Darnall, PhD retweeted
Want better outcomes after surgery? Brief interventions can help surgical patients meaningfully improve their surgical recovery without adding medication.
Source: bit.ly/4bbIZ0a
Beth Darnall, PhD retweeted
A new study of adults with #ChronicPain on long-term prescription opioids found that about half of patients successfully reduced their #opioid use with a patient-centered tapering approach. The findings provide important evidence to guide #OpioidTapering strategies for patients with chronic pain who do not have moderate or severe opioid use disorder. bit.ly/4yankiJ @BethDarnall @DrSeanMackey @StanfordMed @StanfordPain
Speaking at the American Academy of Neurology Annual Meeting today in Chicago and during my session time there are 34 parallel events 😆
Really enjoyed Pitt Pain Day last week -- fabulous event showing all the local innovative pain research. Honored to keynote the event along with Dr. Clifford Woolf, and hatch ideas for collaborative projects 💫
If you are a high school student or undergrad blasting cold emails to university professors in pursuit of a faculty mentor, word of advice:
Do not begin your email with “Hey there!”
Beth Darnall, PhD retweeted
Dr. Theresa Lii is studying how ketamine can “reprogram” the brain’s pain pathways for patients whose chronic pain hasn’t responded to other treatments. Her work is helping uncover who benefits most and how relief can last. Read more:
stanford.io/40kN90s
Beth Darnall, PhD retweeted
New national study yields promising results for multidimensional benefits in rare disease at 3 months @MarfanFdn nature.com/articles/s41598-0…
📢Published Today!
Results for Empowered Relief in Marfan and other rare connective tissues conditions
@MarfanFdn @StanfordPain @StanfordMed nature.com/articles/s41598-0…
Beth Darnall, PhD retweeted
What’s new: A team led by @DesAzizoddin tested Cancer Pain 101, a single-session 90-minute telehealth class with pharmacist, social worker, and psychologist educators.
Interestingly sometimes we have to apply targeted recruitment efforts for *men* to get adequate representation in our pain studies. But i definitely get your point in general
Beth Darnall, PhD retweeted
Original: Drs. Clifton, @BethDarnall, & col. (@Stanford) aimed to address disparities in pain research engagement and patient outcomes through the inclusion of people with varied backgrounds and pain experiences.
Full: jpain.org/article/S1526-5900…
📢VOTING IS OPEN for the United States Association for the Study of Pain (USASP) election!!
Learn more about USASP at usasp.org and be sure to vote for all open Board of Directors positions
Also, clinical trials can be quite burdensome to patients and far from “ideal” in many ways. Studying outcomes of routine care gives a clearer picture of what works and for whom
A new review in @PAINthejournal by @DrSeanMackey and colleagues explains how data from everyday care — called real-world data — can help us understand what truly works for people living with pain.
Why it matters: Clinical trials are done under ideal conditions, but everyday care is far more complex. Real-world evidence fills this gap, showing how treatments work across diverse patients, clinics, and communities.
